59
Views
13
CrossRef citations to date
0
Altmetric
Review

Aliskiren and valsartan combination therapy for the management of hypertension

Pages 711-722 | Published online: 11 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Molly Adams, Jessica M. Bellone, Bradley M. Wright & Gregory W. Rutecki. (2012) Evaluation and Pharmacologic Approach to Patients with Resistant Hypertension. Postgraduate Medicine 124:1, pages 74-82.
Read now

Articles from other publishers (12)

Thomas D. Giles, John R. Cockcroft, Bertram Pitt, Abhijeet Jakate & Harold M. Wright. (2017) Rationale for nebivolol/valsartan combination for hypertension. Journal of Hypertension 35:9, pages 1758-1767.
Crossref
Uwe Zeymer, Ralf Dechend, Thomas Riemer, Evelin Deeg, Jochen Senges, David Pittrow & Roland Schmieder. (2016) Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study. The Journal of Clinical Hypertension 18:7, pages 647-654.
Crossref
Emre MUTLU, Selçuk İLHAN, Elif ONAT, Murat KARA & Engin ŞAHNA. (2016) The effects of novokinin, an AT2 agonist, on blood pressure, vascular responses, and levels of ADMA, NADPH oxidase, and Rho kinase in hypertension induced by NOS inhibition and salt. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 1249-1257.
Crossref
Egidio Imbalzano, Mirko Scarpelli, Giuseppe Mandraffino, Michele Creazzo, Giuseppina Lizio, Giovanni Trapani, Giuseppe Dattilo, Andrea Dalbeni, Carmelo Tomasello, Maria Adriana Sardo & Antonino Saitta. (2014) Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria. Journal of the Renin-Angiotensin-Aldosterone System 16:4, pages 956-964.
Crossref
KV Anil Kumar, Shrasti Nagwar, Rama Thyloor & Sreemantula Satyanarayana. (2014) Anti-stress and nootropic activity of drugs affecting the renin-angiotensin system in rats based on indirect biochemical evidence. Journal of the Renin-Angiotensin-Aldosterone System 16:4, pages 801-812.
Crossref
Thomas D. Giles, George Bakris, Suzanne Oparil, Michael A. Weber, Huiling Li, Madhuja Mallick, David B. Bharucha, ChunLin Chen, William G. Ferguson, John Sorin, Matthew Davis, Joesph IzzoJr.Jr., Nabile Andrawis, Alyn Anderson, Rogelio Bardinas-Rodriguez, Douglas Young, Andrew Schreiber, Cristian Breton, Duane Harris, Phillip LaStella, Ramon Castello, Susan Hole, Joesph Lillo, Luis Carlos Quintero, Carlos Montenegro, Jeffrey Rosen, Farid Marquez, Fredric Adler, Sady Alpizar, James Andersen, Corey Anderson, Graciela Calatayud, Kevin Cannon, Deanna Cheung, Rafel Chiong, Lisa Cohen, Harry Collins, Michael Dao, Cara H. Dawson, Donna DeSantis, Shelly Dunmyer, Sherif El-Harazi, Cecil M. Farrington, David Ferrera, Gregory S. Funk, Gregory Gottschlich, Terence T. Hart, Marvin Kalafer, Dean Kereiakes, Gigi Lefebvre, Aristolis Laliotis, Peter Mattar, Michael McCartney, Diane McConnehey, Curtis Mello, Joel Neutel, Deborah A. Burke, James Pritchard, George Raad, Bruce Rankin, John “Chip” H. Reed, Erich Schramm, Howard Schwartz, Nathan Segall, James Shoemaker, Vakas Sial, Teresa Sligh, William Smith, Richard Stewart, Dan Streja, Danny Sugimoto, Alexander White, Hayes Williams, William Abraham, Azazuddin Ahmed, Richard Beasley, Daniel Gruener, Connie Hsu, Ryan Klein, Allen Soo, Charles P. Andrews, Clinton Corder, Donald Hurley, Elizabeth Bretton, Richard Martinez, David Morin, Miguel Trevino, Samir Arora, Curtis Scott Horn, Charles Lovell, Thomas Nussdorfer, Robert Weiss, Harold Bays, Jackson Rhudy, Edwardo Almaguer, Joseph H. Woolley, Vicki Miller, Jaynier Moya-Hechevarria, Henry Punzi, Addison Taylor, Jonathan Wilson, Arnold Alper, Patricia Buchanan, Richard Dobrusin, Alan Forker, Razmig Krumian, Samuel F. Oberstein, Andrew Lewin, Mary Bella Natividad, Armando Segui, Wayne Harper, Andrea Lawless, Lawrence S. Levinson, Shaukat Shah, Loray Blair-Britt, Patrick Carmichael, Thomas D. Giles, Nathaniel Winer, David Grant, Kyle Rickner, Absalom Tilley, Linda Harper, Stephen Maddock, Joseph A. BosciaIIIIII, Yekaterina Khronusova, Larry D. Reed & Chandar Abboy. (2015) Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension. Journal of the American Society of Hypertension 9:11, pages 845-854.
Crossref
Gregg Lanier, Kedar Sankholkar & Wilbert S. Aronow. (2014) Azilsartan, Aliskiren, and Combination Antihypertensives Utilizing Renin–Angiotensin–Aldosterone System Antagonists. American Journal of Therapeutics 21:5, pages 419-435.
Crossref
Janice E. Sullivan, Deborah Keefe, Yinong Zhou, Lisa Satlin, Hui Fang & Jing-He Yan. (2013) Pharmacokinetics, Safety Profile, and Efficacy of Aliskiren in Pediatric Patients With Hypertension. Clinical Pediatrics 52:7, pages 599-607.
Crossref
U. Zeymer, R. Dechend, E. Deeg, E. Kaiser, J. Senges, D. Pittrow & R. Schmieder. (2012) Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry. International Journal of Clinical Practice 66:3, pages 251-261.
Crossref
Juan C. Ruiz, Ana Sánchez-Fructuoso & Sofía Zárraga. (2012) Management of proteinuria in clinical practice after kidney transplantation. Transplantation Reviews 26:1, pages 36-43.
Crossref
Jamie J. Coleman & Anthony R. Cox. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 317 338 .
Muzaffar Iqbal. (2011) Clinical Perspective on the Management of Hypertension. Indian Journal of Clinical Medicine 2, pages IJCM.S5475.
Crossref